SanaCurrents Following Stock Highs After Coronavirus Developments
Last Friday, the FDA granted emergency use authorization (EUA) to [...]
Call Us: (800) 891-1526
M - F 8AM to 4PM ET
Antibe Pain Relief Drug Catalyst Update
SanaCurrents is closing its position in Antibe this week, due [...]
Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts
One of the strongest performing biopharmaceutical stocks this year is [...]
SanaCurrents Increasing Monthly Sentiment Report Frequency
SanaCurrents is increasing the frequency of its sentiment reports to subscribers [...]
ADMA New Catalysts For 2019 – Two PDUFA decisions on immunodeficiency therapies
SUMMARY SanaCurrents assigns a pivotal sentiment the FDA will approve [...]
Verona Pharma (VRNA) January 2019 Catalyst: Topline data for RPL554
SUMMARY Sana Currents assigns a pivotal sentiment that Verona Pharma [...]
Cara Therapeutics (CARA) Q1 2019 Catalyst: Phase III efficacy trial, KALM-2
SUMMARY Sana Currents assigns a pivotal sentiment that Cara Therapeutics [...]
Karyopharm’s Cancer Drug Achieves Impressive Results
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported impressive results on December 1, 2018 [...]